CORCEPT THERAPEUTICS INC (CORT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 90M 180M 270M Q3 '11: 0 Q4 '11: 0 Q1 '12: 0 Q1 '17: 27.6M Q2 '17: 35.6M Q3 '17: 42.8M Q4 '17: 53.3M Q1 '18: 57.7M Q2 '18: 62.3M Q3 '18: 64.4M Q4 '18: 66.8M Q1 '19: 64.8M Q2 '19: 72.3M Q3 '19: 81.5M Q4 '19: 87.9M Q1 '20: 93.2M Q2 '20: 88.6M Q3 '20: 86.3M Q4 '20: 85.7M Q1 '21: 79.4M Q2 '21: 91.6M Q3 '21: 96.1M Q4 '21: 98.8M Q1 '22: 93.7M Q2 '22: 103.4M Q3 '22: 101.7M Q4 '22: 103.1M Q1 '23: 105.7M Q2 '23: 117.7M Q3 '23: 123.6M Q4 '23: 135.4M Q1 '24: 146.8M Q2 '24: 163.8M Q3 '24: 182.5M Q4 '24: 181.9M Q1 '25: 157.2M Q2 '25: 194.4M Q3 '25: 207.6M Q4 '25: 202.1M Q1 '26: 164.9M Q2 '26: 256.1M Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Gross Profit Quarterly

0 35M 70M 105M Q2 '12: 827K Q3 '12: 1M Q4 '12: 1.4M Q1 '13: 1.7M Q2 '13: 1.9M Q3 '13: 2.6M Q4 '13: 4.1M Q1 '14: 4.2M Q2 '14: 5.6M Q3 '14: 7M Q4 '14: 8.8M Q1 '15: 9.8M Q2 '15: 11.5M Q3 '15: 13M Q4 '15: 14.6M Q1 '16: 15.7M Q2 '16: 19.3M Q3 '16: 21.1M Q4 '16: 23.2M Q1 '17: 27M Q2 '17: 34.8M Q3 '17: 41.8M Q4 '17: 52.1M Q1 '18: 56.5M Q2 '18: 61.2M Q3 '18: 63.1M Q4 '18: 65.3M Q1 '19: 63.6M Q2 '19: 70.9M Q3 '19: 80.1M Q4 '19: 86.5M Q1 '20: 91.4M Q2 '20: 87.3M Q3 '20: 85.1M Q4 '20: 84.5M Q2 '13 Q3 '14 Q4 '15 Q1 '17 Q2 '18 Q3 '19 Q4 '20

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q1 '10: -6.1M Q2 '10: -6.4M Q3 '10: -7.1M Q4 '10: -7.8M Q1 '11: -7.1M Q2 '11: -8.9M Q3 '11: -6.4M Q4 '11: -9.9M Q1 '12: -11M Q2 '12: -7.6M Q2 '12: -7.6M Q3 '12: -7.7M Q4 '12: -10M Q1 '13: -10.9M Q2 '13: -10.8M Q3 '13: -9.7M Q4 '13: -10M Q1 '14: -12.9M Q2 '14: -6.6M Q3 '14: -5.1M Q4 '14: -3.1M Q1 '15: -4M Q2 '15: -1.2M Q3 '15: 102K Q4 '15: 1.7M Q1 '16: 592K Q2 '16: 1.5M Q3 '16: 3.1M Q4 '16: 5M Q1 '17: 4.7M Q2 '17: 12.8M Q3 '17: 13.6M Q4 '17: 21.7M Q1 '18: 21M Q2 '18: 20.6M Q3 '18: 23M Q4 '18: 24.9M Q1 '19: 19M Q2 '19: 24.6M Q3 '19: 33M Q4 '19: 35M Q1 '20: 37.7M Q2 '20: 35.3M Q3 '20: 24.7M Q4 '20: 30.5M Q1 '21: 19.6M Q2 '21: 31.9M Q3 '21: 36.2M Q4 '21: 36.7M Q1 '22: 26.8M Q2 '22: 31.4M Q3 '22: 31.9M Q4 '22: 22.5M Q1 '23: 14.9M Q2 '23: 29.6M Q3 '23: 31.2M Q4 '23: 31.7M Q1 '24: 29.5M Q2 '24: 35.6M Q3 '24: 46.6M Q4 '24: 25.3M Q1 '25: 3.4M Q2 '25: 26.7M Q3 '25: 10.2M Q4 '25: 4.5M Q1 '26: -49.6M Q2 '26: 41.3M Q4 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-35M 0 35M 70M 105M Q1 '10: -6.1M Q2 '10: -5.7M Q3 '10: -7.1M Q4 '10: -7.1M Q1 '11: -7.1M Q2 '11: -8.9M Q3 '11: -6.4M Q4 '11: -9.9M Q1 '12: -11M Q2 '12: -7.6M Q2 '12: -7.6M Q3 '12: -8.3M Q4 '12: -11.1M Q1 '13: -12.1M Q2 '13: -11.9M Q3 '13: -10.9M Q4 '13: -11.1M Q1 '14: -13.9M Q2 '14: -7.6M Q3 '14: -6M Q4 '14: -3.9M Q1 '15: -4.8M Q2 '15: -1.9M Q3 '15: -601K Q4 '15: 959K Q1 '16: -19K Q2 '16: 977K Q3 '16: 2.6M Q4 '16: 4.6M Q1 '17: 4.4M Q2 '17: 12.6M Q3 '17: 13.8M Q4 '17: 98.3M Q1 '18: 17.5M Q2 '18: 18.2M Q3 '18: 17.7M Q4 '18: 22M Q1 '19: 18.3M Q2 '19: 20.2M Q3 '19: 26.3M Q4 '19: 29.4M Q1 '20: 30.1M Q2 '20: 28.3M Q3 '20: 21.6M Q4 '20: 26M Q1 '21: 23.5M Q2 '21: 26.5M Q3 '21: 30.5M Q4 '21: 32.1M Q1 '22: 22.8M Q2 '22: 27.4M Q3 '22: 34.6M Q4 '22: 16.6M Q1 '23: 15.9M Q2 '23: 27.5M Q3 '23: 31.4M Q4 '23: 31.4M Q1 '24: 27.8M Q2 '24: 35.5M Q3 '24: 47.2M Q4 '24: 30.7M Q1 '25: 20.5M Q2 '25: 35.1M Q3 '25: 19.7M Q4 '25: 24.3M Q1 '26: -31.8M Q2 '26: 43M Q4 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 2M 4M 6M Q2 '12: 48K Q2 '12: 48K Q3 '12: 24K Q4 '12: 19K Q1 '13: 20K Q2 '13: 23K Q3 '13: 40K Q4 '13: 61K Q1 '14: 174K Q2 '14: 215K Q3 '14: 235K Q4 '14: 258K Q1 '15: 302K Q2 '15: 439K Q3 '15: 256K Q4 '15: 364K Q1 '17: 646K Q2 '17: 775K Q3 '17: 976K Q4 '17: 1.2M Q1 '18: 1.2M Q2 '18: 1.2M Q3 '18: 1.3M Q4 '18: 1.6M Q1 '19: 1.2M Q2 '19: 1.4M Q3 '19: 1.5M Q4 '19: 1.4M Q1 '20: 1.9M Q2 '20: 1.2M Q3 '20: 1.2M Q4 '20: 1.3M Q1 '21: 1.3M Q2 '21: 1.4M Q3 '21: 1.3M Q4 '21: 1.4M Q1 '22: 1.2M Q2 '22: 1.3M Q3 '22: 1.3M Q4 '22: 1.5M Q1 '23: 1.4M Q2 '23: 1.6M Q3 '23: 1.6M Q4 '23: 1.9M Q1 '24: 2.5M Q2 '24: 2.5M Q3 '24: 2.9M Q4 '24: 3M Q1 '25: 2.4M Q2 '25: 3.4M Q3 '25: 4.6M Q4 '25: 2.5M Q1 '26: 2.9M Q2 '26: 4.1M Q1 '13 Q4 '14 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Operating Cash Flow Quarterly

-25M 0 25M 50M 75M Q3 '10: -6.4M Q4 '10: -5.5M Q1 '11: -7.3M Q2 '11: -7.2M Q3 '11: -6.6M Q4 '11: -6.3M Q1 '12: -10.2M Q2 '12: -7.9M Q3 '12: -9.2M Q4 '12: -8.7M Q1 '13: -11.6M Q2 '13: -9.2M Q3 '13: -8.6M Q4 '13: -7.7M Q1 '14: -11.1M Q2 '14: -9M Q3 '14: -5.9M Q4 '14: -1.4M Q1 '15: -1.8M Q2 '15: -139K Q3 '15: 883K Q4 '15: 4.2M Q1 '16: 3.3M Q2 '16: 1.6M Q3 '16: 8.9M Q4 '16: 4.6M Q1 '17: 9.6M Q2 '17: 15.6M Q3 '17: 10.9M Q4 '17: 24.9M Q1 '18: 34.4M Q2 '18: 15.2M Q3 '18: 44.5M Q4 '18: 21.5M Q1 '19: 23.7M Q2 '19: 25.6M Q3 '19: 38.4M Q4 '19: 48.5M Q1 '20: 33.3M Q2 '20: 53.2M Q3 '20: 30.4M Q4 '20: 35.1M Q1 '21: 25.4M Q2 '21: 44.3M Q3 '21: 48.7M Q4 '21: 49.4M Q1 '22: 35.2M Q2 '22: 18M Q3 '22: 33.6M Q4 '22: 33.4M Q1 '23: 26M Q2 '23: 42.3M Q3 '23: 52.9M Q4 '23: 5.5M Q1 '24: 23.8M Q2 '24: 41.2M Q3 '24: 73.3M Q4 '24: 60.1M Q1 '25: 4.8M Q2 '25: 44.3M Q3 '25: 54.5M Q4 '25: 38.4M Q1 '26: -16.8M Q2 '26: 33.5M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-25M 0 25M 50M 75M Q3 '11: -6.6M Q4 '11: -6.3M Q1 '12: -10.2M Q2 '12: -7.9M Q3 '12: -9.3M Q4 '12: -8.8M Q1 '13: -11.6M Q2 '13: -9.2M Q3 '13: -8.7M Q4 '13: -7.7M Q1 '14: -11.2M Q2 '14: -9M Q3 '14: -5.9M Q4 '14: -1.4M Q1 '15: -1.8M Q2 '15: -139K Q3 '15: 883K Q4 '15: 4.1M Q1 '16: 3.3M Q2 '16: 1.6M Q3 '16: 8.8M Q4 '16: 4.5M Q1 '17: 9.5M Q2 '17: 15.4M Q3 '17: 10.8M Q4 '17: 24.9M Q1 '18: 34.4M Q2 '18: 15.1M Q3 '18: 44.5M Q4 '18: 21.4M Q1 '19: 23.4M Q2 '19: 25.1M Q3 '19: 38.1M Q4 '19: 48.3M Q1 '20: 33.2M Q2 '20: 53.1M Q3 '20: 29.7M Q4 '20: 34.6M Q1 '21: 25.3M Q2 '21: 44.2M Q3 '21: 48.5M Q4 '21: 49.4M Q1 '22: 35.2M Q2 '22: 18M Q3 '22: 33.3M Q4 '22: 33.4M Q1 '23: 26M Q2 '23: 42.2M Q3 '23: 52.9M Q4 '23: 5.5M Q1 '24: 23.8M Q2 '24: 40.8M Q3 '24: 71.7M Q4 '24: 59.9M Q1 '25: 4.7M Q2 '25: 44.2M Q3 '25: 54.5M Q4 '25: 38.4M Q1 '26: -17M Q2 '26: 31M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q2 '15: 107.9M Q3 '15: 108.5M Q1 '16: 109.7M Q2 '16: 115.3M Q3 '16: 116.4M Q1 '17: 121.2M Q2 '17: 123M Q3 '17: 125.7M Q1 '18: 127.7M Q2 '18: 127.5M Q3 '18: 126.2M Q1 '19: 123.9M Q2 '19: 121.8M Q3 '19: 121.8M Q1 '20: 122.2M Q2 '20: 123.2M Q3 '20: 124.5M Q1 '21: 129.7M Q2 '21: 126.7M Q3 '21: 125.1M Q1 '22: 115M Q2 '22: 115.4M Q3 '22: 116.6M Q1 '23: 115.4M Q2 '23: 109.6M Q3 '23: 111.1M Q1 '24: 109.9M Q2 '24: 111.2M Q3 '24: 113.7M Q1 '25: 119.8M Q2 '25: 120.5M Q3 '25: 119.4M Q1 '26: 104.4M Q2 '26: 118.4M Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.50 0.00 0.50 1.00 1.50 Q4 '10: -0.38 Q1 '11: -0.38 Q2 '11: -0.40 Q3 '11: -0.38 Q4 '11: -0.40 Q1 '12: -0.44 Q1 '13: -0.40 Q2 '13: -0.43 Q3 '13: -0.46 Q4 '13: -0.46 Q1 '14: -0.48 Q2 '14: -0.43 Q3 '14: -0.38 Q4 '14: -0.31 Q1 '15: -0.22 Q2 '15: -0.17 Q3 '15: -0.12 Q4 '15: -0.07 Q1 '16: -0.02 Q2 '16: 0.01 Q3 '16: 0.04 Q4 '16: 0.07 Q1 '17: 0.11 Q2 '17: 0.20 Q3 '17: 0.29 Q4 '17: 1.02 Q1 '18: 1.12 Q2 '18: 1.16 Q3 '18: 1.19 Q4 '18: 0.60 Q1 '19: 0.61 Q2 '19: 0.64 Q3 '19: 0.72 Q4 '19: 0.78 Q1 '20: 0.88 Q2 '20: 0.94 Q3 '20: 0.89 Q4 '20: 0.85 Q1 '21: 0.78 Q2 '21: 0.76 Q3 '21: 0.83 Q4 '21: 0.89 Q1 '22: 0.91 Q2 '22: 0.94 Q3 '22: 1.00 Q4 '22: 0.88 Q1 '23: 0.82 Q2 '23: 0.83 Q3 '23: 0.81 Q4 '23: 0.95 Q1 '24: 1.06 Q2 '24: 1.13 Q3 '24: 1.26 Q4 '24: 1.23 Q1 '25: 1.15 Q2 '25: 1.12 Q3 '25: 0.87 Q4 '25: 0.82 Q1 '26: 0.35 Q2 '26: 0.42 Q3 '11 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.